Literature DB >> 1827828

The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region.

S M Canfield1, S L Morrison.   

Abstract

A family of chimeric immunoglobulins (Igs) bearing the murine variable region directed against the hapten dansyl linked to human IgG1, -2, -3, and -4 has been characterized with respect to binding to the human high affinity Fc gamma receptor, Fc gamma RI. Chimeric IgG1 and -3 have the highest affinity association (Ka = 10(9) M-1), IgG4 is 10-fold reduced from this level, and IgG2 displays no detectable binding. A series of genetic manipulations was undertaken in which domains from the strongly binding subclass IgG3 were exchanged with domains from the nonbinding subclass IgG2. The subclass of the CH2 domain was found to be critical for determining IgG receptor affinity. In addition, the hinge region was found to modulate the affinity of the IgG for Fc gamma RI, possibly by determining accessibility of Fc gamma RI to the binding site on Fc. A series of amino acid substitutions were engineered into the CH2 domain of IgG3 and IgG4 at sites considered potentially important to Fc receptor binding based on homology comparisons of binding and nonbinding IgG subclasses. Characterization of these mutants has revealed the importance for Fc gamma RI association of two regions of the genetic CH2 domain separated in primary structure by nearly 100 residues. The first of these is the hinge-link or lower hinge regions, in which two residues, Leu (234) and Leu(235) in IgG1 and -3, are critical to high affinity binding. Substitution at either of these sites reduces the IgG association constant by 10-100-fold. The second region that appears to contribute to receptor binding is in a hinge-proximal bend between two beta strands within the CH2 domain, specifically, Pro(331) in IgG1 and -3. As a result of beta sheet formation within this domain, this residue lies within 11 A of the hinge-link region. Substitution at this site reduces the Fc receptor association constant by 10-fold.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827828      PMCID: PMC2190830          DOI: 10.1084/jem.173.6.1483

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  The valence for ligand of the human mononuclear phagocyte 72 kD high-affinity IgG Fc receptor is one.

Authors:  J H O'Grady; R J Looney; C L Anderson
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

2.  The monocyte binding domain(s) on human immunoglobulin G.

Authors:  J M Woof; M I Nik Jaafar; R Jefferis; D R Burton
Journal:  Mol Immunol       Date:  1984-06       Impact factor: 4.407

3.  Structure and function of immunoglobulin domains. VIII. An analysis of the structural requirements in human IgG1 for binding to the Fc receptor of human monocytes.

Authors:  D E Barnett Foster; K J Dorrington; R H Painter
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

4.  Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells.

Authors:  Z Steplewski; M D Lubeck; H Koprowski
Journal:  Science       Date:  1983-08-26       Impact factor: 47.728

5.  Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.

Authors:  D O Adams; T Hall; Z Steplewski; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

6.  Structural requirements of immunoglobulin G for binding to the Fc gamma receptors of the human tumor cell lines U937, HL-60, ML-1, and K562.

Authors:  D McCool; B K Birshtein; R H Painter
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

7.  Characterization of the Fc receptor for IgG on a human macrophage cell line, U937.

Authors:  C L Anderson; G N Abraham
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

8.  Polymorphonuclear leukocyte function triggered through the high affinity Fc receptor for monomeric IgG.

Authors:  L Shen; P M Guyre; M W Fanger
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

9.  Fc gamma R-mediated killing by eosinophils.

Authors:  R F Graziano; R J Looney; L Shen; M W Fanger
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

10.  Phagocytosis mediated by three distinct Fc gamma receptor classes on human leukocytes.

Authors:  C L Anderson; L Shen; D M Eicher; M D Wewers; J K Gill
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

View more
  73 in total

1.  Development of a specific system for targeting protein to metallophilic macrophages.

Authors:  Philip R Taylor; Susanne Zamze; Richard J Stillion; Simon Y C Wong; Siamon Gordon; Luisa Martinez-Pomares
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

2.  Collagen induces maturation of human monocyte-derived dendritic cells by signaling through osteoclast-associated receptor.

Authors:  Heidi S Schultz; Louise M Nitze; Louise H Zeuthen; Pernille Keller; Albrecht Gruhler; Jesper Pass; Jianhe Chen; Li Guo; Andrew J Fleetwood; John A Hamilton; Martin W Berchtold; Svetlana Panina
Journal:  J Immunol       Date:  2015-02-27       Impact factor: 5.422

Review 3.  Advances in Antibody Design.

Authors:  Kathryn E Tiller; Peter M Tessier
Journal:  Annu Rev Biomed Eng       Date:  2015-08-14       Impact factor: 9.590

4.  Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.

Authors:  David O Beenhouwer; Esther M Yoo; Chun-Wei Lai; Miguel A Rocha; Sherie L Morrison
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

Review 5.  Regulation of antibody effector functions through IgG Fc N-glycosylation.

Authors:  Isaak Quast; Benjamin Peschke; Jan D Lünemann
Journal:  Cell Mol Life Sci       Date:  2016-09-17       Impact factor: 9.261

6.  IgG2m4, an engineered antibody isotype with reduced Fc function.

Authors:  Zhiqiang An; Gail Forrest; Renee Moore; Michael Cukan; Peter Haytko; Lingyi Huang; Salvatore Vitelli; Jing Zhang Zhao; Ping Lu; Jin Hua; Christopher R Gibson; Barrett R Harvey; Donna Montgomery; Dennis Zaller; Fubao Wang; William Strohl
Journal:  MAbs       Date:  2009 Nov-Dec       Impact factor: 5.857

7.  Immunoglobulin subclass determines ability of immunoglobulin (Ig)G to capture and activate neutrophils presented as normal human IgG or disease-associated anti-neutrophil cytoplasm antibody (ANCA)-IgG.

Authors:  T Pankhurst; G Nash; J Williams; R Colman; A Hussain; C Savage
Journal:  Clin Exp Immunol       Date:  2011-03-10       Impact factor: 4.330

8.  Intrachain disulfide bond in the core hinge region of human IgG4.

Authors:  J W Bloom; M S Madanat; D Marriott; T Wong; S Y Chan
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

9.  IgG4 can induce an M2-like phenotype in human monocyte-derived macrophages through FcγRI.

Authors:  Jennifer F A Swisher; Devin A Haddad; Anna G McGrath; Gunther H Boekhoudt; Gerald M Feldman
Journal:  MAbs       Date:  2014       Impact factor: 5.857

10.  Transferrin-antibody fusion proteins are effective in brain targeting.

Authors:  S U Shin; P Friden; M Moran; T Olson; Y S Kang; W M Pardridge; S L Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.